Schwindel bei kardiologischen Erkrankungen

Abstract

Dizziness is a symptom that may be of cardiac origin. Diagnosis and treatment of cardiac diseases is of important prognostic impact. Dizziness may be caused due to two different cardiac disorders: (1) as symptom of a cardioembolic event or (2) as a symptom of a low cardiac output leading to an intermittent global cerebral hypoperfusion. This review article presents diagnostic as well as therapeutic pathways in a comprehensive tabular overview.

Schwindel ist sowohl Symptom als auch Folge von Herzerkrankungen: Zu unterscheiden sind der Schwindel als Symptom einer kardioembolischen Ursache und der Schwindel als Folge der Abnahme des Herzzeitvolumens mit daraus resultierender globaler passagerer Gehirnhypoperfusion. Korrekte Diagnose und Therapie sind prognoseentscheidend – dieser Beitrag stellt u. a. Diagnostik- und Behandlungspfade konzentriert in tabellarischer Form vor.

Schlüsselwörter

Schwindel - Herzerkrankung - Diagnostik - Therapie

Key words

dizziness - cardiac disease - heart - diagnostic - treatment

• Literatur

• 1 Brignole M, Moya A, de Lange FJ. et al. ESC Scientific Document Group: 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J 2018; 39: 1883-1948
• 2 Brignole M, Auricchio A, Baron-Esquivias G. et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the ESC. Developed in collaboration with EHRA. Europace 2013; 15: 1070-1118
• 3 Priori SG, Blomström-Lundqvist C, Mazzanti A. et al. ESC Scientific Document Group: 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death; endorsed by AEPC. Eur Heart J 2015; 36: 2793-2867
• 4 Schleifer JW, Shen WK. Vasovagal syncope: an update on the latest pharmacological therapies. Expert Opin Pharmacother 2015; 16: 501-513
• 5 Varosy PD, Chen LY, Miller AL. et al. Pacing as a Treatment for Reflex-Mediated (Vasovagal, Situational, or Carotid Sinus Hypersensitivity) Syncope: A Systematic Review for the 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope. J Am Coll Cardiol 2017; 70: 664-679
• 6 Kirchhof P, Benussi S, Kotecha D. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace 2016; 18: 1609-1678
• 7 Blomström-Lundqvist C, Scheinman MM, Aliot EM. et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias – executive summary. A report for practice guidelines developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol 2003; 42: 1493-1531
• 8 Baumgartner H, Falk V, Bax JJ. et al. ESC Scientific Document Group: 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38: 2739-2791
• 9 Saver JL, Carroll JD, Thaler DE. et al. RESPECT Investigators: Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke. N Engl J Med 2017; 377: 1022-1032
• 10 Galiè N, Humbert M, Vachiery JL. et al. ESC Scientific Document Group: 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension; endorsed by AEPC and ISHLT. Eur Heart J 2016; 37: 67-119